| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000027114 |
| Receipt No. | R000031070 |
| Official scientific title of the study | Promotion of exploratory research into healthy and ocular diseases biomarkers discovery in Taiwa medical examination |
| Date of disclosure of the study information | 2017/04/24 |
| Last modified on | 2017/04/24 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Promotion of exploratory research into healthy
and ocular diseases biomarkers discovery in Taiwa medical examination |
|
| Title of the study (Brief title) | Healthy and ocular diseases biomarkers discovery | |
| Region |
|
|
| Condition | ||
| Condition | Subjects received Taiwa medical examination. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To investigate normal range for various biomarkers, including genome, protein, oxidative stress, ocular structure, blood flow and visual field for subjects received Taiwa medical examination. |
| Basic objectives2 | Others |
| Basic objectives -Others | To analyze bioactive compound, cytokines, proteome, metabolome, nucleic acid, autoantibodiesa and oxidative stress in blood and urine samples. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To determine the normal range of various ocular parameters, including visual acuity, refractive error, OCT, Humphrey Frequency Doubling Technology Perimetry, IOL master, Laser speckle flowgraphy. |
| Key secondary outcomes | To analyze bioactive compound, cytokines, proteome, metabolome, nucleic acid, autoantibodiesa and oxidative stress in blood and urine samples. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Having written consent for participation in this study. | |||
| Key exclusion criteria | Subjects who do not consent in this study. | |||
| Target sample size | 600 | |||
| Research contact person | |
| Name of lead principal investigator | Toru Nakazawa |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Ophthalmology |
| Address | 1-1, Seryo-machi, Aoba-ku, Sendai city, Miyagi, Japan |
| TEL | 022-717-7294 |
| ntoru@oph.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Hiroshi Kunikata |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Ophthalmology |
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai city, Miyagi, Japan |
| TEL | 022-717-7294 |
| Homepage URL | |
| kunikata@oph.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University Graduate School of Medicine.
Department of Ophthalmology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | To investigate normal range for various biomarkers, including genome, protein, oxidative stress, ocular structure, blood flow and visual field for subjects received Taiwa medical examination.
In addition, we analyze bioactive compound, cytokines, proteome, metabolome, nucleic acid, autoantibodiesa and oxidative stress in blood and urine samples. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031070 |